Biohaven Pharmaceutical Holding Company Ltd. BHVN
$ 36.29
2.69%
Quarterly report 2022-Q2
added 12-16-2023
Country |
USA |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NYSE |
CEO |
Mr. Vlad Coric |
Employees in the company |
647 |
Shares |
64.7 M |
Market Cap[1] |
$ 2.35 B |
EBITDA (LTM) |
$ -651 M |
P/E (LTM) |
-2.59 |
P/S (LTM) |
4.26 |
EPS (LTM) |
-15.04 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.